Clinical Trials Directory

Trials / Completed

CompletedNCT01268111

Effect of Vitamin D Replacement on Insulin Sensitivity

Effect of Vitamin D Supplementation on Insulin Sensitivity and Retinol-binding Protein 4 Levels in Subjects With Vitamin D Deficiency

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Texas Tech University Health Sciences Center · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Healthy subjects with low Vitamin D levels will be randomly assigned to either Vitamin D replacement or placebo for a period of 8 weeks. Insulin sensitivity will be measured before and after the intervention, and the changes will be compared between the two groups. This will help us understand if Vitamin D replacement improves insulin sensitivity. Serum Retinol Binding Protein 4 levels will also be measured to see if changes in insulin sensitivity are mediated by RBP4.

Conditions

Interventions

TypeNameDescription
DRUGErgocalciferolsERgocaclciferol 50,000 units weekly for 8 weeks
DRUGPlacebomatching placebo

Timeline

Start date
2011-01-01
Primary completion
2012-03-01
Completion
2012-03-01
First posted
2010-12-29
Last updated
2015-06-08
Results posted
2013-05-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01268111. Inclusion in this directory is not an endorsement.